← All Sponsors
SPONSOR

Pedro de Figueiredo Buchalla

Total Trials
1
Recruiting
1
Phases
Phase 4

Pedro de Figueiredo Buchalla is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Nephrolithiasis, Alpha Blocker, Ureteral Access Sheath.

The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Pedro de Figueiredo Buchalla

How many clinical trials has Pedro de Figueiredo Buchalla sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Pedro de Figueiredo Buchalla, of which 1 are actively recruiting participants. These trials cover conditions including Nephrolithiasis, Alpha Blocker, Ureteral Access Sheath. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Pedro de Figueiredo Buchalla research focus on?
Pedro de Figueiredo Buchalla clinical trials span Nephrolithiasis, Alpha Blocker, Ureteral Access Sheath. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Pedro de Figueiredo Buchalla clinical trial?
To participate in a Pedro de Figueiredo Buchalla trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Pedro de Figueiredo Buchalla trials with current recruitment status updated daily.

Clinical Trials by Pedro de Figueiredo Buchalla

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology